| Significance of various anticoagulation therapies during use of a left ventricular assist device. | |
| | |
MedLine Citation:
|
PMID: 2597495 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A multicomparative study to establish adequate anticoagulation therapy for left ventricular assist devices was undertaken by administrating various anticoagulants: heparin, a prostacyclin analogue combined with a protease inhibitor; thromboxane A2 synthetase inhibitor; or a protease inhibitor alone. Our investigation suggested that combined administration of prostacyclin analogue and protease inhibitor (FUT-175) is ideal anticoagulation therapy from the point of blood coagulation and fibrinolysis. Currently, however, sole administration of FUT-175 is adequate anticoagulation therapy during clinical use of left ventricular assist devices. |
| | |
Authors:
|
T Takahama; F Kanai; M Hiraishi; K Onishi; Z Yamazaki; Y Naruse; A Furuse; T Yoshitake |
Related Documents
:
|
1093505 - Anticoagulants in cerebrovascular disease. a critical review of studies. 3133215 - Lupus anticoagulant and lacunar infarctions. 7681375 - Defibrotide. a review of its pharmacodynamic and pharmacokinetic properties, and therap... 8358885 - Lone atrial fibrillation and anticoagulant therapy. 19910105 - Polymyositis presenting with cardiac manifestations: report of two cases and review of ... 11103755 - Myocardial efficiency during levosimendan infusion in congestive heart failure. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: ASAIO transactions / American Society for Artificial Internal Organs Volume: 35 ISSN: 0889-7190 ISO Abbreviation: ASAIO Trans Publication Date: 1989 Jul-Sep |
Date Detail:
|
Created Date: 1990-02-06 Completed Date: 1990-02-06 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 8611947 Medline TA: ASAIO Trans Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 426-9 Citation Subset: IM |
Affiliation:
|
First Department of Surgery, Saitama Medical Center, Saitama Medical College, Tokyo, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
administration & dosage* Blood Coagulation Tests Factor XII / metabolism Fibrinogen / metabolism Guanidines / administration & dosage Heart-Assist Devices* Heparin / administration & dosage Humans Methacrylates / administration & dosage Platelet Aggregation / drug effects Platelet Aggregation Inhibitors / therapeutic use Platelet Count / drug effects alpha-2-Antiplasmin / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Guanidines; 0/Methacrylates; 0/Platelet Aggregation Inhibitors; 0/alpha-2-Antiplasmin; 81525-10-2/nafamostat; 82571-53-7/ozagrel; 9001-30-3/Factor XII; 9001-32-5/Fibrinogen; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of varying dialysate bicarbonate concentration on serum phosphate.
Next Document: Mean flow velocity patterns within a ventricular assist device.